Summary of SCCM Congress in San Diego, California: CPP Section Activities Strategic Planning Meeting -Clinical Pharmacy & Pharmacology (CPP) Section Advisory Board:
Short, intermediate and long term goals were reviewed and revised Committee Charges were reviewed and revised Joe Dasta and Fellowship grants documents were finalized and sent for approval and distribution to other Sections to be used as template Incorporation of procurement and distribution of funds policy into grant policy Development of Task Force on Critical Care Pharmacy Workforce Issues to be chaired by Steve Martin and Keith Olsen Discussion of Annals of Internal Medicine paper on Pharmacist's Scope of Care written and endorsed by the American College of Physicians -American Society of Internal Medicine without pharmacy input; will develop response letter to Annals with review by SCCM Council for possible authorship from pharmacy, physician section, and nursing (ASHP, ACCP, and APhA developing response letter as well)
CPP Section Member Reception
Our member reception was a huge success thanks to the work of our Membership Committee chaired by John Devlin and Eric Wittbrodt. Thanks also to Ed Sypniewski of Bayer for financial support of the food and beverages. The door prizes were a great idea. We had a great turnout with well over 100 people in attendance. We were fortunate enough to have David Martin, SCCM CEO and Ann Thompson, SCCM Past-President stop by for some food, drink, and fellowship. Hopefully many of you will be able to join us again at the next reception in San Antonio!
Annual CPP Business Meeting
The Business meeting was well attended and provided a great forum for all CPP members to share ideas and voice concerns. The meeting began with a short report from the Chair and each Committee Chair. The floor was then open for election of new officers. All in attendance who had not previously voted online were given the chance to vote by paper ballot. Election results are as follows: Chair-Elect (John Devlin), Secretary/Treasurer (Martin Ohlinger), Members-At-Large (Denise Rhoney and Terry Walker).
Many CPP members exchanged meaningful dialogue on several issues including the Joe Dasta and Fellowship grant and how to increase the number of applicants and assist our members with writing and submitting proposals, discussions on web capabilities for our members, pharmacy workforce issues and many other topics. Thanks to all those members that attended and contributed! Congratulations to Steve Martin who was inducted as a Fellow to the American College of Critical Care Medicine at Congress (FCCM designation)! Section Elections at the 2003 Congress in San Antonio will include Chair-Elect (3 year term; 1 year each as Chair-Elect, Chair, and Past Chair) and a Member-at-Large seat (2 year term). It is never too early to start thinking about becoming increasingly involved in the leadership of our Section!
Pharmacy Outcomes Grant Available To Section Members
The SCCM/Bayer Joseph F. Dasta Critical Care Outcomes Grant will be awarded this Spring 2002, following the reopening of the proposal application period, and again in September 2002. The Dasta grant provides up to $30,000 for a CPP member(s) for research on health outcomes related to critical care pharmacy practice or pharmacotherapy. Outcomes may be clinical, economic, or humanistic.
Research findings must be presented at the SCCM Critical Care Congress within two years of receipt of the award. The grant is sponsored by Bayer Corporation, through the efforts of CPP member Ed Sypniewski, Jr, PharmD, FCCM. Bayer has funded the grant each of the three years that it has been offered, and has also supplied a generous endowment for the continued funding of this important research award. Past winners include Jane DeLemos and Rob MacLaren, BSC, PharmD.
Outcomes Fellowship Also Available
The SCCM/CPP Critical Care Outcomes Pharmacy Fellowship, sponsored by Ortho Biotech, will also be awarded this spring 2002. This award of $30,000 is to provide funding for a pharmacist to pursue critical care outcomes research experience and training. This award is established to foster exemplary science in the critical care discipline, and promote new and existing fellowship training programs. It will be awarded to an SCCM/CPP member serving as a mentor for a post-doctoral fellowship.
The award emphasizes the need for critical care pharmacy outcomes research, including a clinical, economical, or humanistic approach, and the necessary training programs to provide this quality research. The Section hopes to foster new fellowship training programs in the critical care pharmacy discipline through the awarding of this grant. CPP member Terry Walker, PharmD was instrumental in securing significant funding from Ortho Biotech for this award as well as an endowment program to sustain the award in the future. Last year, Denise Rhoney, PharmD received the award, which helped her to initiate a new fellowship program.
Opportunity for Another Section Member on Council: Please Vote
Erkan Hassan, PharmD (VISICU, Baltimore, Maryland) has agreed to run for an At-Large Seat on Council for the 2003 election. This would give the CPP Section another seat on Council in addition to Judi Jacobi, PharmD, FCCM. Erkan's nomination will go to the SCCM Nominating Committee. The slate of candidates must be approved by the entire Council before going to all SCCM members for election. Council members are elected by a plurality of the valid votes cast by secret ballot. In recent years, ballots have been mailed to all SCCM members in the fall and the results are announced at the SCCM Annual Business Meeting held at the Annual Congress (Symposium). These ballots usually have a short turn-around time, so all CPP Section members are strongly advised to keep mailing addresses with SCCM current in order that ballots are received in a timely manner. We will follow-up with the section once the Nominating committee has determined its list of candidates. The Section has established a Task Force to define and promote the critical care pharmacist and critical care pharmacy services. This Task Force has grown out of CPP member needs assessments that have been performed over the last several years. The Task Force has been charged with the following agenda:
• Survey the country's hospitals to quantify the number of pharmacist practitioners, and establish the level of clinical pharmacy practice in the care of critically ill patients.
• Prepare a comprehensive packet of information for members, Directors of Pharmacy, and Institutional Administrators. The packet should provide current guidelines, literature, or other information to assist in (justify) the retention and recruitment of pharmacists practicing clinical pharmacy services in the critical care area.
• Externally (to CPP) promote the inclusion of the pharmacist as a vital member of the intensivist-led, multidisciplinary team.
• Quantify the critical care pharmacist shortage.
• Externally (to CPP) disseminate the critical care pharmacist manpower issues.
If you would like to join the Task Force to promote critical care pharmacists and pharmacy services, please email either co-chair Steve Martin at smartin2@utnet.utoledo.edu or Keith Olsen at, kolsen@unmc.edu.
Membership Committee Update
By Gail Gesin, PharmD The SCCM-CPP summer Strategic Planning Meeting is in the works. The SCCM-CPP Advisory Board and committee chairs will attend this meeting, held in Chicago at the SCCM home office. The meeting is being planned for June or July with exact dates forthcoming. The strategic plan and goals as well as the vision and mission statements of the section will be discussed. The current vision and mission statements of the section are as follows:
The Clinical Pharmacy and Pharmacology Section envisions a multidisciplinary model that ensures optimal pharmacotherapeutic outcomes for all critically ill patients.
Mission Statement:
The Clinical Pharmacy and Pharmacology Section is a diverse group of professionals whose mission is to provide preeminent pharmacy leadership and collaboration in critical care practice education and research.
Watch upcoming newsletters for more information about the meeting. For questions or more specific details about the meeting please contact Martin Ohlinger, PharmD. If there are any ideas about specific topics or issues to be discussed at the meeting please contact any Advisory Board member or committee chair. 
SCCM Committees Need Pharmacy Members
Pharmacy representation is needed on a number of Society-wide committees. In addition to CPP Section Committees, SCCM offers multiple options for multidisciplinary committee involvement.
If you are interested in serving on any of the following committees please contact Annie Herrington, CPP Chair. As a critical care pharmacy resident, every day presents a new challenge. My first priority and most important role as a critical care pharmacist is that of patient care and being an integral part of the multidisciplinary team to influence patient outcomes. Physicians, as well as patients and their families, look to me as a resource for drug information. Included with patient care, daily responsibilities are comprised of recommendations for drug therapy, recognition of drug-related events, reduction of medical errors, and cost containment measures. There are two characteristics of a critical care pharmacist that are very appealing to me. One of which is being involved in every aspect of the patient, from infectious disease to nutrition support. The other is the ability to sub-specialize in a particular area of intensive care, such as medicine, surgery, burn, and my area of interest, neurotrauma.
Becoming a member of SCCM as a pharmacy resident last year was important to me in many different ways. The organization is committed to education and research, which is evident at the annual Critical Care Congress in the review of topics and presentations of ongoing research areas. The Clinical Pharmacy and Pharmacology (CPP) Section within SCCM allows for networking among colleagues and the opportunity for collaboration in research and education. At this year's Critical Care Congress I attended the CPP Section business meeting and witnessed the great deal of support within the section for its members, not only for professional development, but also for the future of the section itself. Furthermore, SCCM allows the opportunity to present research at a higher scientific level with expert peer review. Lastly, with regard to research, funding is available in SCCM through grants for research and post-doctorate fellowships to further its members' success.
How to Write an Abstract

By Keith Olsen, PharmD and Sandy Kane, PharmD
Abstracts submitted to a medical or pharmacy meeting or as part of a scientific article, have often been terse statements describing the research question. The outcome is often a poorly written, rambling abstract that may result in rejection or impair the evaluation of the scientific reviewer. Because many of the same mistakes in abstract writing are repeated from year to year, the Clinical Pharmacy and Pharmacology Section of the Society of Critical Care Medicine (SCCM) has charged the research committee to develop a "How-to-Guide" to writing better abstracts for submission to the annual SCCM Congress.
As authors of over 110 abstracts, we suggest following the steps below to increase the chance for abstract acceptance. We make the assumption in writing your abstract; the data is sound and with appropriate supporting evidence in study design. Thus, writing a clear concise abstract significantly enhances the chances for acceptance. Since abstracts are brief in nature, but highly informative, we have chosen to use brevity as well. However, this should not diminish from the content describe herein and following these simple rules increases the acceptance rate of an abstract. 
Continued from Page 7
Concise and Specific -Be as brief as possible, but still deliver your message. Remember most abstracts range from 150 to 250 words.
Coherent writing -Write in a clear manor. Authorities suggest using verbs rather than noun equivalent and the active rather than the passive. Use the present tense to describe results and past tense to describe specific variables manipulated or tests applied. If an abstract would be more appropriate in another category or section, please indicate where it should be placed in COMMENT. For abstracts graded below 6 (six), please indicate in the COMMENT box a reason (s) for rejection. This information will be provided to the authors as an educational tool.
Tables or Figures -
Note:
We have provided a check box titled "newsworthy"; if you find an abstract that you believe is worthy of media attention, please indicate that by checking this box.
Each abstract must be given a NUMERICAL grade based on the following criteria:
GRADE EXPLANATION
9-10 Excellent -Investigation based on original concepts, is methodologically sound, results factually and accurately displayed and analyzed, and provides important data or new techniques; conclusion appropriate to data and original. Should be accepted for presentation.
7-8
Good -Similar to above but less outstanding; may consist of replication of important concept in new environment, may contain minor methodological flaws. Should be accepted for presentation.
5-6
Average -Contains information, which might benefit the literature and coworkers; contains fair data. Hypothesis tested is not clearly stated, methods not appropriate or complete, statistical evaluation not present when appropriate, conclusions overstated. May be presented. General guide for abstract scoring. Please note that some abstracts may be important and excellent but due to subject matter may not be structured in the following manner.
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